The current role of model-based drug development

By Suryawanshi Satyendra   Zhang Liping   Pfister Marc   Meibohm Bernd  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 4, 2010-04 ,pp. : 311-321

Informa Healthcare

Access to resources Recommend Favorite

Model‐Based Evaluation of Radiation and Radiosensitizing Agents in Oncology

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 7, Iss. 1, 2018-01 ,pp. : 51-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacodynamic Biomarkers in Model-Based Drug Development in Oncology

By  

Current Clinical Pharmacology, Vol. 6, Iss. 1, 2011-02 ,pp. : 30-40

Bentham Science Publishers

Access to resources Recommend Favorite

Real-time reverse transcription-polymerase chain reaction analysis of translation initiation factor 1A (eIF-1A) in human and mouse preimplantation embryos

By Lindeberg M   Hovatta O   Ährlund-Richter L  

Reproductive BioMedicine Online, Vol. 8, Iss. 3, 2004-03 ,pp. : 338-343

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study

By Cheng Ting-Yuan David   Makar Karen W.   Neuhouser Marian L.   Miller Joshua W.   Song Xiaoling   Brown Elissa C.   Beresford Shirley A. A.   Zheng Yingye   Poole Elizabeth M.   Galbraith Rachel L.   Duggan David J.   Habermann Nina   Bailey Lynn B.   Maneval David R.   Caudill Marie A.   Toriola Adetunji T.   Green Ralph   Ulrich Cornelia M.  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3684-3691

Blackwell Publishing

Access to resources Recommend Favorite